Amylyx Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
AMLX Nasdaq 2830 amylyx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals Announces U.S. Expanded Access Program for Adults with Post-Bariatric Hypoglycemia - May 5th, 2026 5:00 am
Amylyx Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026 - Apr 30th, 2026 7:00 am
Amylyx Pharmaceuticals Sets Up Q3 Phase 3 Avexitide Data Readout, Eyes Potential 2027 Launch - Apr 15th, 2026 2:02 pm
Amylyx Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference - Apr 8th, 2026 7:00 am
Amylyx Pharmaceuticals (AMLX) Winds Up Avexitide Phase 3 Lucidity Trial Enrollment - Mar 31st, 2026 5:34 am
Is LUCIDITY Trial Completion in Post-Bariatric Hypoglycemia Altering The Investment Case For Amylyx Pharmaceuticals (AMLX)? - Mar 28th, 2026 5:03 pm
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Amid Economic Data Releases - Mar 24th, 2026 7:13 am
Amylyx Pharmaceuticals Announces Completion of Enrollment in Pivotal Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia - Mar 24th, 2026 5:00 am
Amylyx Pharmaceuticals Highlights Avexitide LUCIDITY Phase 3 Enrollment, Q3 Data Timing at Leerink Conf. - Mar 10th, 2026 7:52 pm
Amylyx Pharmaceuticals Inc (AMLX) Q4 2025 Earnings Call Highlights: Strategic Advances and ... - Mar 4th, 2026 6:02 pm
A Look At Amylyx Pharmaceuticals (AMLX) Valuation After Reduced Losses And Late Stage Pipeline Progress - Mar 4th, 2026 4:08 am
Amylyx Pharmaceuticals Says 2026 Could Be “Transformative” Ahead of Avexitide Phase 3 Readout - Mar 4th, 2026 1:57 am
Amylyx Refocuses On Avexatide As LUCIDITY Milestone Raises Stakes - Mar 3rd, 2026 10:10 pm
Amylyx Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary - Mar 3rd, 2026 10:32 am
Amylyx Pharmaceuticals Q4 Earnings Call Highlights - Mar 3rd, 2026 9:18 am
Amylyx (AMLX) Q4 2025 Earnings Call Transcript - Mar 3rd, 2026 7:40 am
Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results - Mar 3rd, 2026 5:00 am
Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences - Feb 26th, 2026 7:00 am
Apogee Therapeutics Stock Up 100% as Fund Lifts Stake to $28 Million - Feb 25th, 2026 1:26 pm
This Fund Bet $20 Million on RAPT Therapeutics as Stock Surges 500% This Past Year and Buyout Offer Emerges - Feb 25th, 2026 1:19 pm